X-108440165-T-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_033380.3(COL4A5):ā€‹c.40T>Gā€‹(p.Leu14Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000119 in 1,096,636 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 20)
Exomes š‘“: 0.000012 ( 0 hom. 5 hem. )

Consequence

COL4A5
NM_033380.3 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 1.19
Variant links:
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13906804).
BS2
High Hemizygotes in GnomAdExome4 at 5 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL4A5NM_033380.3 linkuse as main transcriptc.40T>G p.Leu14Val missense_variant 1/53 ENST00000328300.11 NP_203699.1
COL4A5NM_000495.5 linkuse as main transcriptc.40T>G p.Leu14Val missense_variant 1/51 NP_000486.1
COL4A5XM_047441811.1 linkuse as main transcriptc.40T>G p.Leu14Val missense_variant 1/42 XP_047297767.1
COL4A5XM_047441810.1 linkuse as main transcriptc.-337T>G 5_prime_UTR_variant 1/54 XP_047297766.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL4A5ENST00000328300.11 linkuse as main transcriptc.40T>G p.Leu14Val missense_variant 1/531 NM_033380.3 ENSP00000331902 P29400-2

Frequencies

GnomAD3 genomes
Cov.:
20
GnomAD3 exomes
AF:
0.00000551
AC:
1
AN:
181494
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
66228
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000119
AC:
13
AN:
1096636
Hom.:
0
Cov.:
29
AF XY:
0.0000138
AC XY:
5
AN XY:
362052
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000155
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
20
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineSep 18, 2019The p.Leu14Val variant in COL4A5 has not been previously reported in individuals with Alport syndrome but has been identified in 0.001% (1/81016) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). Computational prediction tools and conservation analysis suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2, BP4. -
X-linked Alport syndrome Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Sep 10, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.059
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.097
.;T
FATHMM_MKL
Benign
0.35
N
LIST_S2
Benign
0.60
T;T
M_CAP
Benign
0.037
D
MetaRNN
Benign
0.14
T;T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
0.0
N;N
MutationTaster
Benign
0.96
N;N
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.080
N;N
REVEL
Benign
0.20
Sift
Benign
0.28
T;T
Sift4G
Benign
0.20
T;T
Polyphen
0.0050
.;B
Vest4
0.33
MutPred
0.45
Loss of helix (P = 0.0444);Loss of helix (P = 0.0444);
MVP
0.63
MPC
0.30
ClinPred
0.090
T
GERP RS
3.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.11
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs760570519; hg19: chrX-107683395; API